CVBD Easy-To-digest No 2 Coinfection
CVBD Easy-To-digest No 2 Coinfection
CVBD Easy-To-digest No 2 Coinfection
2 July 2008
www.cvbd.org
®
CVBD DIGEST
A challenge for the practitioner –
co-infection with
vector-borne pathogens in dogs
Cutting-edge information brought to you by the CVBD® World Forum
®
CVBD DIGEST No. 02 July 2008
A challenge for the practitioner – co-infection with vector-borne pathogens in dogs
Introduction
When Bayer Animal Health called for the 1st International CVBD® Symposium
in 2006, this was the first and initial step to address the global threat of canine
vector-borne diseases (CVBD). This was based on the belief that vector-borne
diseases of the dog should be treated as one topic and dealt with on a global
level and in an interdisciplinary way. Especially with increasing international
travel and emerging climate change, CVBD have become a global issue and
even sparked public interest. Many of the parasite-transmitted diseases affect
humans as well as animals. The dog as man’s best friend plays an important
role – being affected to a high extend by and serving as a host for some of the
zoonotic pathogens.
At the first symposium, the participants agreed to form the CVBD® World
Forum. Besides gathering knowledge, the main task for this group of inter-
national experts has been to raise awareness for the specific regional risks of
CVBD and to foster preventative measures. For this reason, the CVBD® World
Forum created a website (www.cvbd.org) to provide the veterinary practitioner
with cutting-edge and clinically relevant scientific information on CVBD.
In CVBD® Digest, relevant findings from the International CVBD® Symposia are
presented periodically to veterinary practitioners. While the first edition was on
“asymptomatic leishmaniosis in dogs”, the second edition is about co-infection
with CVBD-causing pathogens. During the three symposia so far, it became clear
that beside the transmission of multiple pathogens by one vector, high
attention has to be paid to co-infection with pathogens arising from different
vectors, like ticks and sand flies. Furthermore, the difficulties in clinical diag-
nosis and the complex interaction of different infectious agents, e.g. via the
canine immune system, make co-infection with CVBD-causing pathogens a
substantial concern for veterinarians throughout the world.
®
No. 02 July 2008
A challenge for the practitioner – co-infection with vector-borne pathogens in dogs CVBD DIGEST 3
Tab. 1: Canine tick-borne pathogens. Listed are genus and species of transmitting ticks, important transmitted pathogens and their
endemic regions. Many of these pathogens are also causing diseases in humans.
®
6 CVBD DIGEST No. 02 July 2008
A challenge for the practitioner – co-infection with vector-borne pathogens in dogs
widely and are often • show atypical clinical signs of the suspected
non-specific, such as disease;
chronic wasting, weight • live in endemic areas for years without any signs
loss, poor appetite, fe- of disease and suddenly fall ill with a suspected
ver, anemia, non-pruri- mono-infection of a CVBD.
tic alopecia and skin
erosions or ulcerations. Anamnesis and searching for typical clinical-patho-
Variation is expected logical findings, accompanied by laboratory results,
to be a consequence are key clinical diagnostic approaches. However,
Fig. 5: Inclusion bodies of of pathogen- or host- these findings might be mimicked and altered by
Ehrlichia canis from a co-infection as it is suspected for epistaxis. It has
dog also infected with specific factors, but
Leishmania infantum can also be related to long been thought and taught a cardinal sign in
(® photo by Roura X.,
co-infection with other ehrlichiosis, but is possibly caused by an underlying
Barcelona, Spain)
vector-borne pathogens Bartonella infection in E. canis-positive dogs 4 (Fig. 6).
in some individuals.10 An increasing number of pub- Thus, it may become very difficult to attribute the
lications report on simultaneous infections with clinical signs and hematological and/or biochemical
additional vector-borne pathogens in Leishmania- abnormalities to a single specific pathogen. Never-
infected dogs 11–13, like Ehrlichia (Fig. 5), Anaplasma, theless, the veterinary practitioner should follow a
Babesia, Bartonella, Rickettsia and Hepatozoon spe- standard examination procedure: detailed anam-
cies as well as mosquito-transmitted Dirofilaria repens. netic report, profound clinical and laboratory exam-
ination, including search for typical signs, and
Even though some authors do not expect concurrent additional serological and molecular identification
infections e.g. with L. infantum to substantially in- of multiple patho-
fluence the clinical course and final outcome of gens, which offer a
chronic canine ehrlichiosis11, others presume the more successful di-
immunosuppression caused by cutano-visceral leish- agnostic approach
maniosis to promote the occurrence of co-infection apart from only
with other pathogens14 and discuss a synergism clinical and labora-
between leishmaniosis and ehrlichiosis in altering tory parameters. It
platelet function by different pathways.15 Likewise, should be consid-
an epidemiological study from Italy found Neospora ered, however, that
caninum seroreactivity to represent a major risk molecular or sero- Fig. 6: Labrador retriever referred
logical evidence of for evaluation of chronic
factor for L. infantum seroreactivity.16 polyarthritis, seizures, epis-
a pathogen alone, taxis and endocarditis. The
without any clini- dog was co-infected with
Ehrlichia canis and Bartonella
Diagnosis of vector-borne co-infections cal signs, does not vinsonii subspecies berkhoffii.
represent a proof (® photo by Breitschwerdt, E.B.,
Raleigh, USA)
The clinical signs of dogs infected with more than one for a disease.
pathogen are often non-specific and very variable.
Thus, when approaching a dog, e.g. with leish-
maniosis, any clinical sign of the patient should be Control of vector-borne co-infections
investigated and co-infection should be clarified
in dogs that The different infection scenarios with vector-
borne pathogens in dogs call for a comprehensive
• lack response to conventional treatment (e.g., control program. Sequential transmission, concur-
persistence of hypergammaglobulinemia, per- rently or over a time, by ticks and other vectors such
sistence of high antibody titer); as mosquitoes (Dirofilaria spp. transmission) and
®
No. 02 July 2008
A challenge for the practitioner – co-infection with vector-borne pathogens in dogs CVBD DIGEST 7
especially sand flies (L. infantum / L. chagasi trans- feeding if possible. Broad-spectrum ectoparasiticides
mission) has to be taken into account. Furthermore, with repellent properties, such as the synthetic
epidemiological studies revealed new distribution pyrethroid permethrin, are ideal compounds to reach
patterns of vectors, so that previously non-endemic this goal 17, as they prevent the biting of different
regions may be endemic today. As a consequence, vectors like ticks, fleas, sand flies and mosquitoes
veterinary practitioners are advised to bear in mind and therefore minimize the host-parasite inter-
differential diagnoses of diseases formerly not action, thus resulting in a decreased risk of disease
occurring in the respective region. transmission. A regular treatment with these com-
pounds during the transmission period, e.g. in form
Prevention of arthropod bites is mainly achieved by of monthly spot-on applications, is crucial for the
preventing the attachment and thus further blood- prevention of single as well as multiple CVBD.
References
1. Bourdoiseau, G.*, Bonnefont, C., Magnol, J.P., Saint-André, I., Chabanne, L. (1997): Lymphocyte subset abnormalities in
canine leishmaniasis. Vet. Immunol. Immunopathol. 56, 345–351
2. Guarga, J.L., Moreno, J., Lucientes, J., Gracia, M.J., Peribáñez, M.A., Alvar, J., Castillo, J.A. (2000): Canine leishmaniasis
transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of
T helper cells. Res. Vet. Sci. 69, 249–253
3. Straubinger, R.K.*, Krupka, I., Pantchev, N., Lorentzen, L., Weise,M. (2008): Single and dual infections with Anaplasma
phagocytophilum and Borrelia burgdorferi sensu lato in German dogs – a serological research study. Proc. 3rd Canine
Vector-Borne Disease (CVBD) Symposium, Wiesbaden, Germany, April 16-19, 2008, pp 46–54
4. Breitschwerdt, E.B.* (2007): Canine and feline anaplasmosis: Emerging infectious diseases. Proc. 2nd Canine Vector-Borne
Disease (CVBD) Symposium, Sicily, Italy, April 25–28, 2007, pp 6–14
5. Kordick, S.K., Breitschwerdt, E.B.*, Hegarty, B.C., Southwick, K.L., Colitz, C.M., Hancock, S.I., Bradley, J.M., Rumbough,
R., Mcpherson, J.T., MacCormack, J.N. (1999): Coinfection with multiple tick-borne pathogens in a Walker Hound kennel
in North Carolina. J. Clin. Microbiol. 37, 2631–2638
6. Skotarczak, B., Rymaszewska, A., Wodecka, B., Sawczuk, M. (2003): Molecular evidence of coinfection of Borrelia
burgdorferi sensu lato, human granulocytic ehrlichiosis agent, and Babesia microti in ticks from northwestern Poland.
J. Parasitol. 89, 194–196
7. Thomas, V., Anguita, J., Barthold, S.W., Fikrig, E. (2001): Coinfection with Borrelia burgdorferi and the agent of human
granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis.
Infect. Immun. 69, 3359–3371
8. Krause, P.J., McKay, K., Thompson, C.A., Sikand, V.K., Lentz, R., Lepore, T., Closter, L., Christianson, D., Telford, S.R., Persing,
D., Radolf, J.D., Spielman, A.; Deer-Associated Infection Study Group (2002): Disease-specific diagnosis of coinfecting
tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin. Infect. Dis. 34, 1184–1191
9. Beall, M.J., Chandrashekar, R., Eberts, M.D., Cyr, K.E., Diniz, P.P., Mainville, C., Hegarty, B.C., Crawford, J.M.,
Breitschwerdt, E.B.* (2008): Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum,
and Ehrlichia species in dogs from Minnesota. Vector Borne Zoonotic Dis. 2008, Feb 27 [Epub ahead of print]
10. Solbach, W., Laskay, T. (2000): The host response to Leishmania infection. Adv. Immunol. 74, 275–317
11. Mylonakis, M.E., Koutinas, A.F., Breitschwerdt, E.B.*, Hegarty, B.C., Billinis, C.D., Leontides, L.S., Kontos, V.S. (2004):
Chronic canine ehrlichiosis (Ehrlichia canis): A retrospective study of 19 natural cases. J. Am. Anim. Hosp. Assoc. 40, 174–184
12. Tarello, W. (2002): Dermatitis associated with Dirofilaria (Nochtiella) repens microfilariae in dogs from central Italy.
Acta Vet. Hung. 50, 63–78
13. Gaskin, A.A., Schantz, P., Jackson, J., Birkenheuer, A., Tomlinson, L., Gramiccia, M., Levy, M., Steurer, F., Kollmar, E., Hegarty,
B.C., Ahn, A., Breitschwerdt, E.B.* (2002): Visceral leishmaniasis in a New York foxhound kennel. J. Vet. Intern. Med. 16, 34–44
14. Andreotti, R., Oliveira, J.M., Silva, E.A., Oshiro, L.M., Matos, M. de F. (2006): Occurrence of Neospora caninum in dogs
and its correlation with visceral leishmaniasis in the urban area of Campo Grande, Mato Grosso do Sul, Brazil.
Vet. Parasitol. 135, 375–379
15. Cortese, L., Pelagalli, A., Piantedosi, D., Mastellone, V., Manco, A., Lombardi, P., Ciaramella, P., Avallone, L. (2006):
Platelet aggregation and haemostatic response in dogs naturally co-infected by Leishmania infantum and Ehrlichia canis.
J. Vet. Med. A Physiol. Pathol. Clin. Med. 53, 546–548
16. Cringoli, G., Rinaldi, L., Capuano, F., Baldi, L., Veneziano, V., Capelli, G.* (2002): Serological survey of Neospora caninum
and Leishmania infantum co-infection in dogs. Vet. Parasitol. 106, 307–313
17. Dryden, M. (2006): Challenges and solutions to tick control. Suppl. Comp. Cont. Educ. Pract. Vet. 28, 10–13
www.cvbd.org